Publications

Browse our publications catalogue to learn about our research.

Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label study

J.J. Wykrzykowska, A. Warnholtz, P. De Jaeger, N. Curzen, K.G. Oldroyd, J.P. Collet, J.M. Ten Berg, T. Rademaker, D. Goedhart, J. Lissens, P.P. Kint & P.W. Serruys, 2009, Journal of Thrombosis and Thrombolysis, 28(4), 410-417

DOI: 10.1007/s11239-009-0354-y

Type: article

Percutaneous coronary intervention of ostial lesions

P Jokhi & N. Curzen, 2009, EuroIntervention, 5(4), 511-514

DOI: 10.4244/EIJV5I4A81

Type: article

The balloon pump-assisted coronary intervention study (BCIS-1): rationale and design

D. Perera, R. Stables, J. Booth, M. Thomas, S. Redwood & N. Curzen, 2009, American Heart Journal, 158(6), 910-916

DOI: 10.1016/j.ahj.2009.09.015

Type: article

The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease

J.J. Brugtts, M.P. De Maat, E. Boersma & N. Curzen, 2009, Cardiovascular Drugs and Therapy, 23(2), 171-181

DOI: 10.1007/s10557-008-6156-1

Type: article

Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy

Alex R. Hobson, Graham Petley, Geraint Morton, Keith D. Dawkins & Nick P. Curzen, 2008, Thrombosis Journal, 6(1), 1-6

DOI: 10.1186/1477-9560-6-1

Type: article